Healthcare

While a recent accounting adjustment made headlines, shares of Primis Financial Corp. have been staging a remarkable and somewhat unexpected...

Flowers Foods finds itself navigating a complex market transition as consumer preferences shift away from traditional bread products. The company's...

Nuvectis Pharma is making significant strides with its promising drug candidate, NXP900. The biopharmaceutical company has successfully completed a Phase...

In a notable strategic departure, biopharmaceutical firm Ocugen has announced a $5 million equity investment in fellow biotechnology company Carisma...

Friday's trading session revealed cracks in the artificial intelligence rally that has propelled technology stocks to dizzying heights for months....

enVVeno Medical's stock continued its dramatic descent on Friday, registering an additional 8.14% decline. This sustained sell-off was triggered by...

Australian biotechnology firm Immuron has initiated an unusually proactive communication strategy as it approaches two critical clinical milestones. The developer...

Renalytix AI shares are facing significant turbulence as UBS Group AG has completely divested its substantial stake in the artificial...

Industrial technology firm Idex finds itself navigating turbulent waters as divergent forces shape its trajectory. While a strategic acquisition in...

Pulmatrix Inc. is executing a profound strategic transformation, marked by its pending merger with Cullgen and the complete divestiture of...